Reports of Radiotherapy and Oncology

Published by: Kowsar

Toxicity of Adjuvant Radiotherapy in Patients with Breast Cancer: A Review Study

Seyed Alireza Javadinia 1 , Mansoureh Dehghani 1 , Gordon A. Ferns 2 , Soodabeh Shahid Sales 3 , * and Amir Avan 3 , *
Authors Information
1 Student Research Committee, Department of Radiation Oncology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
2 Department of Medical Education, Brighton and Sussex Medical School Brighton and Sussex Medical School, Division of Medical Education, Falmer, Brighton, Sussex UK
3 Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Corresponding Authors:
Article information
  • Reports of Radiotherapy and Oncology: December 31, 2018, 5 (1); e89328
  • Published Online: February 3, 2019
  • Article Type: Review Article
  • Received: January 15, 2019
  • Accepted: January 30, 2019
  • DOI: 10.5812/rro.89328

To Cite: Javadinia S A, Dehghani M , Ferns G A , Shahid Sales S, Avan A. Toxicity of Adjuvant Radiotherapy in Patients with Breast Cancer: A Review Study, Rep Radiother Oncol. 2018 ; 5(1):e89328. doi: 10.5812/rro.89328.

Abstract
Copyright © 2019, Reports of Radiotherapy and Oncology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Cardiac Toxicity
3. Pulmonary Toxicity
4. Cutaneous Toxicity
5. Conclusions
Acknowledgements
Footnotes
References
  • 1. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233-41. doi: 10.1056/NEJMoa022152. [PubMed: 12393820].
  • 2. van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000;92(14):1143-50. [PubMed: 10904087].
  • 3. Veronesi U, Salvadori B, Luini A, Greco M, Saccozzi R, del Vecchio M, et al. Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients. Eur J Cancer. 1995;31A(10):1574-9. [PubMed: 7488404].
  • 4. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet. 2005;366(9503):2087-106. doi: 10.1016/S0140-6736(05)67887-7. [PubMed: 16360786].
  • 5. Early Breast Cancer Trialists' Collaborative G, Darby S, McGale P, Correa C, Taylor C, Arriagada R, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707-16. doi: 10.1016/S0140-6736(11)61629-2. [PubMed: 22019144]. [PubMed Central: PMC3254252].
  • 6. Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015;373(4):317-27. doi: 10.1056/NEJMoa1415369. [PubMed: 26200978].
  • 7. Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, et al. Regional nodal irradiation in early-stage breast cancer. N Engl J Med. 2015;373(4):307-16. doi: 10.1056/NEJMoa1415340. [PubMed: 26200977]. [PubMed Central: PMC4556358].
  • 8. Darby SC, Cutter DJ, Boerma M, Constine LS, Fajardo LF, Kodama K, et al. Radiation-related heart disease: Current knowledge and future prospects. Int J Radiat Oncol Biol Phys. 2010;76(3):656-65. doi: 10.1016/j.ijrobp.2009.09.064. [PubMed: 20159360]. [PubMed Central: PMC3910096].
  • 9. Feng M, Moran JM, Koelling T, Chughtai A, Chan JL, Freedman L, et al. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys. 2011;79(1):10-8. doi: 10.1016/j.ijrobp.2009.10.058. [PubMed: 20421148]. [PubMed Central: PMC2937165].
  • 10. Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005;6(8):557-65. doi: 10.1016/S1470-2045(05)70251-5. [PubMed: 16054566].
  • 11. Hooning MJ, Aleman BM, van Rosmalen AJ, Kuenen MA, Klijn JG, van Leeuwen FE. Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study. Int J Radiat Oncol Biol Phys. 2006;64(4):1081-91. doi: 10.1016/j.ijrobp.2005.10.022. [PubMed: 16446057].
  • 12. Gagliardi G, Constine LS, Moiseenko V, Correa C, Pierce LJ, Allen AM, et al. Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S77-85. doi: 10.1016/j.ijrobp.2009.04.093. [PubMed: 20171522].
  • 13. Taylor CW, McGale P, Povall JM, Thomas E, Kumar S, Dodwell D, et al. Estimating cardiac exposure from breast cancer radiotherapy in clinical practice. Int J Radiat Oncol Biol Phys. 2009;73(4):1061-8. doi: 10.1016/j.ijrobp.2008.05.066. [PubMed: 18973978].
  • 14. Azizova TV, Muirhead CR, Moseeva MB, Grigoryeva ES, Vlasenko EV, Hunter N, et al. Ischemic heart disease in nuclear workers first employed at the Mayak PA in 1948-1972. Health Phys. 2012;103(1):3-14. doi: 10.1097/HP.0b013e3182243a62. [PubMed: 22647906].
  • 15. Nielsen MH, Berg M, Pedersen AN, Andersen K, Glavicic V, Jakobsen EH, et al. Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: National guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group. Acta Oncol. 2013;52(4):703-10. doi: 10.3109/0284186X.2013.765064. [PubMed: 23421926].
  • 16. Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, et al. The UK standardisation of breast radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013;14(11):1086-94. doi: 10.1016/S1470-2045(13)70386-3. [PubMed: 24055415].
  • 17. Appelt AL, Vogelius IR, Bentzen SM. Modern hypofractionation schedules for tangential whole breast irradiation decrease the fraction size-corrected dose to the heart. Clin Oncol (R Coll Radiol). 2013;25(3):147-52. doi: 10.1016/j.clon.2012.07.012. [PubMed: 22910644].
  • 18. Roychoudhuri R, Robinson D, Putcha V, Cuzick J, Darby S, Moller H. Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: A population-based study. BMC Cancer. 2007;7:9. doi: 10.1186/1471-2407-7-9. [PubMed: 17224064]. [PubMed Central: PMC1784099].
  • 19. Formenti SC, DeWyngaert JK, Jozsef G, Goldberg JD. Prone vs supine positioning for breast cancer radiotherapy. JAMA. 2012;308(9):861-3. doi: 10.1001/2012.jama.10759. [PubMed: 22948692].
  • 20. Kirby AM, Evans PM, Donovan EM, Convery HM, Haviland JS, Yarnold JR. Prone versus supine positioning for whole and partial-breast radiotherapy: A comparison of non-target tissue dosimetry. Radiother Oncol. 2010;96(2):178-84. doi: 10.1016/j.radonc.2010.05.014. [PubMed: 20561695].
  • 21. Mast ME, van Kempen-Harteveld L, Heijenbrok MW, Kalidien Y, Rozema H, Jansen WP, et al. Left-sided breast cancer radiotherapy with and without breath-hold: Does IMRT reduce the cardiac dose even further? Radiother Oncol. 2013;108(2):248-53. doi: 10.1016/j.radonc.2013.07.017. [PubMed: 24044804].
  • 22. Florescu M, Cinteza M, Vinereanu D. Chemotherapy-induced cardiotoxicity. Maedica (Buchar). 2013;8(1):59-67. [PubMed: 24023601]. [PubMed Central: PMC3749765].
  • 23. Halyard MY, Pisansky TM, Dueck AC, Suman V, Pierce L, Solin L, et al. Radiotherapy and adjuvant trastuzumab in operable breast cancer: Tolerability and adverse event data from the NCCTG phase III trial N9831. J Clin Oncol. 2009;27(16):2638-44. doi: 10.1200/JCO.2008.17.9549. [PubMed: 19349549]. [PubMed Central: PMC2690390].
  • 24. Belkacemi Y, Gligorov J, Ozsahin M, Marsiglia H, De Lafontan B, Laharie-Mineur H, et al. Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: Acute toxicity analyses from the French multicentric study. Ann Oncol. 2008;19(6):1110-6. doi: 10.1093/annonc/mdn029. [PubMed: 18344537].
  • 25. Meattini I, Cecchini S, Muntoni C, Scotti V, De Luca Cardillo C, Mangoni M, et al. Cutaneous and cardiac toxicity of concurrent trastuzumab and adjuvant breast radiotherapy: A single institution series. Med Oncol. 2014;31(4):891. doi: 10.1007/s12032-014-0891-x. [PubMed: 24535610].
  • 26. Abid SH, Malhotra V, Perry MC. Radiation-induced and chemotherapy-induced pulmonary injury. Curr Opin Oncol. 2001;13(4):242-8. [PubMed: 11429481].
  • 27. Rubin P, Finkelstein J, Shapiro D. Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: Interrelationship between the alveolar macrophage and the septal fibroblast. Int J Radiat Oncol Biol Phys. 1992;24(1):93-101. [PubMed: 1512168].
  • 28. Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein JN. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys. 1995;33(1):99-109. doi: 10.1016/0360-3016(95)00095-G. [PubMed: 7642437].
  • 29. Vujaskovic Z, Marks LB, Anscher MS. The physical parameters and molecular events associated with radiation-induced lung toxicity. Semin Radiat Oncol. 2000;10(4):296-307. [PubMed: 11040330].
  • 30. Vujaskovic Z, Anscher MS, Feng QF, Rabbani ZN, Amin K, Samulski TS, et al. Radiation-induced hypoxia may perpetuate late normal tissue injury. Int J Radiat Oncol Biol Phys. 2001;50(4):851-5. [PubMed: 11429211].
  • 31. Holli K, Pitkanen M, Jarvenpaa R, Rajala J, Lahtela S, Hyodynmaa S, et al. Early skin and lung reactions in breast cancer patients after radiotherapy: Prospective study. Radiother Oncol. 2002;64(2):163-9. [PubMed: 12242126].
  • 32. Smith LM, Mendenhall NP, Cicale MJ, Block ER, Carter RL, Million RR. Results of a prospective study evaluating the effects of mantle irradiation on pulmonary function. Int J Radiat Oncol Biol Phys. 1989;16(1):79-84. [PubMed: 2912958].
  • 33. Sunyach MP, Falchero L, Pommier P, Perol M, Arpin D, Vincent M, et al. Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small-cell lung cancer: Preliminary results. Int J Radiat Oncol Biol Phys. 2000;48(2):459-63. [PubMed: 10974462].
  • 34. Epler GR. Post-breast cancer radiotherapy bronchiolitis obliterans organizing pneumonia. Expert Rev Respir Med. 2013;7(2):109-12. doi: 10.1586/ers.13.1. [PubMed: 23547987].
  • 35. Gagliardi G, Bjohle J, Lax I, Ottolenghi A, Eriksson F, Liedberg A, et al. Radiation pneumonitis after breast cancer irradiation: Analysis of the complication probability using the relative seriality model. Int J Radiat Oncol Biol Phys. 2000;46(2):373-81. [PubMed: 10661344].
  • 36. Lind PA, Wennberg B, Gagliardi G, Fornander T. Pulmonary complications following different radiotherapy techniques for breast cancer, and the association to irradiated lung volume and dose. Breast Cancer Res Treat. 2001;68(3):199-210. [PubMed: 11727957].
  • 37. Meattini I, Guenzi M, Fozza A, Vidali C, Rovea P, Meacci F, et al. Overview on cardiac, pulmonary and cutaneous toxicity in patients treated with adjuvant radiotherapy for breast cancer. Breast Cancer. 2017;24(1):52-62. doi: 10.1007/s12282-016-0694-3. [PubMed: 27025498].
  • 38. Kubo A, Osaki K, Kawanaka T, Furutani S, Ikushima H, Nishitani H. Risk factors for radiation pneumonitis caused by whole breast irradiation following breast-conserving surgery. J Med Invest. 2009;56(3-4):99-110. [PubMed: 19763021].
  • 39. Kahan Z, Csenki M, Varga Z, Szil E, Cserhati A, Balogh A, et al. The risk of early and late lung sequelae after conformal radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys. 2007;68(3):673-81. doi: 10.1016/j.ijrobp.2006.12.016. [PubMed: 17350177].
  • 40. Rancati T, Wennberg B, Lind P, Svane G, Gagliardi G. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models. Radiother Oncol. 2007;82(3):308-16. doi: 10.1016/j.radonc.2006.12.001. [PubMed: 17224197].
  • 41. Woel RT, Munley MT, Hollis D, Fan M, Bentel G, Anscher MS, et al. The time course of radiation therapy-induced reductions in regional perfusion: A prospective study with >5 years of follow-up. Int J Radiat Oncol Biol Phys. 2002;52(1):58-67. [PubMed: 11777622].
  • 42. Koc M, Polat P, Suma S. Effects of tamoxifen on pulmonary fibrosis after cobalt-60 radiotherapy in breast cancer patients. Radiother Oncol. 2002;64(2):171-5. [PubMed: 12242127].
  • 43. Azria D, Larbouret C, Cunat S, Ozsahin M, Gourgou S, Martineau P, et al. Letrozole sensitizes breast cancer cells to ionizing radiation. Breast Cancer Res. 2005;7(1):R156-63. doi: 10.1186/bcr969. [PubMed: 15642164]. [PubMed Central: PMC1064115].
  • 44. Varga Z, Cserhati A, Kelemen G, Boda K, Thurzo L, Kahan Z. Role of systemic therapy in the development of lung sequelae after conformal radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys. 2011;80(4):1109-16. doi: 10.1016/j.ijrobp.2010.03.044. [PubMed: 21549513].
  • 45. Henson KE, McGale P, Taylor C, Darby SC. Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer. Br J Cancer. 2013;108(1):179-82. doi: 10.1038/bjc.2012.575. [PubMed: 23257897]. [PubMed Central: PMC3553540].
  • 46. Pavy JJ, Denekamp J, Letschert J, Littbrand B, Mornex F, Bernier J, et al. EORTC Late Effects Working Group. Late effects toxicity scoring: The SOMA scale. Int J Radiat Oncol Biol Phys. 1995;31(5):1043-7. [PubMed: 7713775].
  • 47. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31(5):1341-6. doi: 10.1016/0360-3016(95)00060-C. [PubMed: 7713792].
  • 48. Harris JR, Levene MB, Svensson G, Hellman S. Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys. 1979;5(2):257-61. [PubMed: 110740].
  • 49. Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ; Start Trialists' Group, et al. The UK standardisation of breast radiotherapy (START) trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial. Lancet. 2008;371(9618):1098-107. doi: 10.1016/S0140-6736(08)60348-7. [PubMed: 18355913]. [PubMed Central: PMC2277488].
  • 50. Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ; Start Trialists' Group, et al. The UK standardisation of breast radiotherapy (START) trial A of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial. Lancet Oncol. 2008;9(4):331-41. doi: 10.1016/S1470-2045(08)70077-9. [PubMed: 18356109]. [PubMed Central: PMC2323709].
  • 51. Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362(6):513-20. doi: 10.1056/NEJMoa0906260. [PubMed: 20147717].
  • 52. Bartelink H, Maingon P, Poortmans P, Weltens C, Fourquet A, Jager J, et al. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. Lancet Oncol. 2015;16(1):47-56. doi: 10.1016/S1470-2045(14)71156-8. [PubMed: 25500422].
  • 53. Livi L, Meattini I, Marrazzo L, Simontacchi G, Pallotta S, Saieva C, et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer. 2015;51(4):451-63. doi: 10.1016/j.ejca.2014.12.013. [PubMed: 25605582].
  • 54. Jagsi R, Ben-David MA, Moran JM, Marsh RB, Griffith KA, Hayman JA, et al. Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys. 2010;76(1):71-8. doi: 10.1016/j.ijrobp.2009.01.041. [PubMed: 19409733]. [PubMed Central: PMC4414125].
  • 55. Olivotto IA, Whelan TJ, Parpia S, Kim DH, Berrang T, Truong PT, et al. Interim cosmetic and toxicity results from RAPID: A randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy. J Clin Oncol. 2013;31(32):4038-45. doi: 10.1200/JCO.2013.50.5511. [PubMed: 23835717].
  • 56. Chargari C, Toillon RA, Macdermed D, Castadot P, Magne N. Concurrent hormone and radiation therapy in patients with breast cancer: What is the rationale? Lancet Oncol. 2009;10(1):53-60. doi: 10.1016/S1470-2045(08)70333-4. [PubMed: 19111245].
  • 57. Hanna YM, Baglan KL, Stromberg JS, Vicini FA, A Decker D. Acute and subacute toxicity associated with concurrent adjuvant radiation therapy and paclitaxel in primary breast cancer therapy. Breast J. 2002;8(3):149-53. [PubMed: 12047471].
  • 58. Ismaili N, Mellas N, Masbah O, Elmajjaoui S, Arifi S, Bekkouch I, et al. Concurrent chemoradiotherapy in adjuvant treatment of breast cancer. Radiat Oncol. 2009;4:12. doi: 10.1186/1748-717X-4-12. [PubMed: 19351405]. [PubMed Central: PMC2679760].
  • 59. Livi L, Meattini I, Scotti V, Saieva C, Simontacchi G, Marrazzo L, et al. Concomitant adjuvant chemo-radiation therapy with anthracycline-based regimens in breast cancer: A single centre experience. Radiol Med. 2011;116(7):1050-8. doi: 10.1007/s11547-011-0652-2. [PubMed: 21424317].
  • 60. Albornoz CR, Matros E, McCarthy CM, Klassen A, Cano SJ, Alderman AK, et al. Implant breast reconstruction and radiation: A multicenter analysis of long-term health-related quality of life and satisfaction. Ann Surg Oncol. 2014;21(7):2159-64. doi: 10.1245/s10434-014-3483-2. [PubMed: 24740825].
  • 61. Chawla AK, Kachnic LA, Taghian AG, Niemierko A, Zapton DT, Powell SN. Radiotherapy and breast reconstruction: Complications and cosmesis with TRAM versus tissue expander/implant. Int J Radiat Oncol Biol Phys. 2002;54(2):520-6. [PubMed: 12243831].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments